Back to News
Feb 18, 2026 12:10 PM

Earnings Outlook For Travere Therapeutics

Travere Therapeutics (NASDAQ:TVTX) will release its quarterly earnings report on Thursday, 2026-02-19. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Travere Therapeutics to report an earnings per share (EPS) of $0.24.

The market awaits Travere Therapeutics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Historical Earnings Performance

In the previous earnings release, the company beat EPS by $0.76, ...